Madison Mid Cap Fund Divests Microchip Technology Inc. Due to Valuation Recovery
Money

Madison Mid Cap Fund Divests Microchip Technology Inc. Due to Valuation Recovery

authorBy Ramit Sethi
DateMar 11, 2026
Read time2 min

Madison Mid Cap Fund has strategically exited its investment in Microchip Technology Inc. (MCHP), a move prompted by the semiconductor company's notable valuation rebound. This decision aligns with the fund's established philosophy of prioritizing businesses with robust quality and profitability, even as the broader market saw a shift towards more speculative ventures. Despite a challenging year for the fund that saw a slight dip in performance compared to its benchmark, the managers remain confident in their long-term investment strategy and their ability to capitalize on emerging opportunities.

Microchip Technology, a prominent American semiconductor firm specializing in smart, connected, and secure embedded control solutions, has demonstrated considerable market resilience. As of March 10, 2026, MCHP shares closed at $65.33, reflecting a remarkable 25.88% increase over the preceding 52 weeks, despite a recent one-month decline of 19.10%. The company boasts a substantial market capitalization of $35.35 billion, underscoring its significant presence in the industry.

In their fourth-quarter 2025 investor letter, Madison Mid Cap Fund specifically addressed their decision to divest from Microchip Technology. The fund acknowledged MCHP's leadership in analog and microcontroller technologies, benefiting from extended product lifecycles and diverse market applications. The company had previously navigated supply chain disruptions, which led to customers over-ordering. However, with the return of founder Steve Sanghi to the CEO role, significant progress has been made in mitigating excess inventory and recalibrating the company for renewed market share growth. While commending Sanghi's initiatives, the fund's decision to sell its stake was primarily driven by the stock's recovered valuation, aligning with their disciplined investment approach.

The investment landscape for Microchip Technology also shows a dynamic interest among hedge funds. According to recent data, 61 hedge fund portfolios held MCHP at the close of the fourth quarter, an increase from 56 in the prior quarter. This suggests a continued, albeit evolving, institutional interest in the company. Nevertheless, Madison Mid Cap Fund's exit underscores a selective approach, where valuation recovery dictates portfolio adjustments, even for companies with strong underlying fundamentals.

This strategic move by Madison Mid Cap Fund exemplifies a proactive portfolio management strategy, where investment decisions are carefully weighed against market valuations and the fund's long-term objectives. The fund's managers are continuously assessing the market to identify and leverage opportunities while adhering to their core principles of investing in high-quality, profitable enterprises.

More Articles
Oklo's Strategic Ascent: Geopolitical Shifts and Domestic Partnerships Drive Nuclear Energy Momentum
Oklo Inc. (NYSE: OKLO) is experiencing a notable rise in market sentiment, with its momentum score increasing amidst escalating geopolitical tensions and the company's strengthened domestic operations. Despite a year-to-date decline, the stock's significant annual growth highlights a renewed focus on advanced nuclear energy due to global uranium supply concerns and strategic partnerships.
By Dave RamseyMar 11, 2026
Jim Cramer's Outlook on Lumentum's Market Performance and S&P 500 Inclusion
Financial analyst Jim Cramer discusses Lumentum Holdings Inc.'s recent market surge and its addition to the S&P 500, highlighting the company's strong ties to AI infrastructure through fiber optic products. Despite its rapid growth and high valuation, Cramer advises caution, suggesting that while the stock has seen massive gains, its current trajectory might make it a risky investment for new buyers.
By JL CollinsMar 11, 2026
Jim Cramer's View on Molina Healthcare: A Deep Dive into Its Market Performance
Jim Cramer has offered critical insights into Molina Healthcare's market standing, particularly its significant exposure to government-backed health programs like Medicare and Medicaid. He characterizes these segments as the less robust areas within the healthcare business, noting the company's substantial stock decline over two years and linking it to the S&P 500 reshuffle. Despite past positive remarks on its service model, Cramer now suggests exploring AI stocks for better potential returns.
By Vicki RobinMar 11, 2026
Top Analyst Forecasts for Wednesday's Trading
This report details the latest insights from leading Wall Street analysts concerning several prominent stocks. It includes changes in price targets and ratings, offering a concise overview of expert opinions to guide investors in their trading decisions for the upcoming Wednesday.
By JL CollinsMar 11, 2026
Bitcoin's Path to $1 Million: A Deep Dive into Market Dynamics
A recent report by Bitwise's Chief Investment Officer, Matt Hougan, suggests that Bitcoin could reach a valuation of $1 million per coin within a decade. This projection hinges on the store-of-value market expanding to $121 trillion and Bitcoin capturing a 17% market share, a significant increase from its current 4%. The analysis draws parallels with gold's historical growth and highlights the increasing institutional adoption of Bitcoin as key drivers for this ambitious forecast.
By Mr. Money MustacheMar 11, 2026